SCHEMBL212724

SCHEMBL212724

O=C(O)C1=Cc2ccccc2OC1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.64
SMN1; SMN2 Q16637 6/20 0.56
NPC1 O15118 5/20 0.56
RAB9A P51151 5/20 0.56
MAPT P10636 4/20 0.56
NFKB1 P19838 3/20 0.56
NFKB2 Q00653 3/20 0.56
RELA Q04206 3/20 0.56
KMT2A Q03164 3/20 0.56
MEN1 O00255 2/20 0.56
CASP3 P42574 1/20 0.56
SENP8 Q96LD8 1/20 0.56
SENP7 Q9BQF6 1/20 0.56
SENP6 Q9GZR1 1/20 0.56
KDM4E B2RXH2 6/20 0.52
MAOB P27338 4/20 0.52
ALDH1A1 P00352 4/20 0.52
MAOA P21397 3/20 0.52
HPGD P15428 1/20 0.52
PKM P14618 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16397645 1.00 ALOX5 (0.64) ALOX5SMN1; SMN2NPC1RAB9AMAPT
Hydrochloric Acid SCHEMBL23532714 0.98 ALOX5 (0.62) ALOX5SMN1; SMN2NPC1RAB9AMAPT
SCHEMBL27648673 0.98 ALOX5 (0.62) ALOX5SMN1; SMN2NPC1RAB9AMAPT
Hydrochloric Acid SCHEMBL5770308 0.98 ALOX5 (0.62) ALOX5SMN1; SMN2NPC1RAB9AMAPT
SCHEMBL14013658 0.84 ALOX5 (0.59) ALOX5SMN1; SMN2NPC1RAB9AMAPT
SCHEMBL9058393 0.84 ALOX5 (0.67) ALOX5SMN1; SMN2NPC1RAB9AMAPT
SCHEMBL2154729 0.84 ALOX5 (0.62) ALOX5SMN1; SMN2NPC1RAB9AMAPT
SCHEMBL31560392 0.84 ALOX5 (0.62) ALOX5SMN1; SMN2NPC1RAB9AMAPT
SCHEMBL545827 0.84 ALOX5 (0.62) ALOX5SMN1; SMN2NPC1RAB9AMAPT
SCHEMBL16335219 0.84 SMN1; SMN2 (0.62) ALOX5SMN1; SMN2NPC1RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 324 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4297874-A1 NONAUTOLOGOUS MULTI-STRESSED CANCER CELLS AND USES THEREOF FOR VACCINATING AND TREATING CANCERS BRENUS PHARMA (FR) 2024-01-03 EP claimed
CN-116730967-A Synthesis method of chroman-3-formic acid 安徽大学 2023-09-12 CN claimed
WO-2022180251-A1 NONAUTOLOGOUS MULTI-STRESSED CANCER CELLS AND USES THEREOF FOR VACCINATING AND TREATING CANCERS BRENUS PHARMA (FR) 2022-09-01 WO claimed
CN-106928046-B A kind of salicylic preparation method of 3,4,5,6- tetrafluoro 常州佳德医药科技有限公司 2019-10-18 CN claimed
CN-105636943-B Chromene derivatives as inhibitors of the TCR-Nck interaction 阿塔克斯生物制药有限公司 2019-01-22 CN claimed
CN-106632190-B 7-(diethylamino) -2- oxo -2H- chromene -3- carboxylic acid preparation method 山西大学 2018-12-07 CN claimed
CN-104860914-B Sulfur pentafluoride replaces benzopyrans compounds and its application 中国科学院广州生物医药与健康研究院 2018-09-14 CN claimed
CN-108069929-A 3- substituted cumarins analog derivative and the agonist of application and GPR35 receptors 中国科学院大连化学物理研究所 2018-05-25 CN claimed
CN-107868069-A The preparation technology of the carboxylic acid of 7 hydroxyl, 8 methyl, 6 nitro, 2 oxygen 2H chromenes 3 山东新华制药股份有限公司 2018-04-03 CN claimed
CN-106928046-A A kind of salicylic preparation method of 3,4,5,6 tetrafluoros 常州佳德医药科技有限公司 2017-07-07 CN claimed
WO-2005000294-A1 SELECTIVE INHIBITOR AND AN ANTICONVULSANT AGENT FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS PHARMACIA CORPORATION (US) 2005-01-06 WO claimed
WO-2005000297-A1 TREATMENT OF MIGRAINE ACCOMPANIED BY NAUSEA PHARMACIA CORPORATION (US) 2005-01-06 WO claimed
WO-2004093816-A2 COMPOSITIONS COMPRISING A SELECTIVE COX-2 INHIBITOR AND A CALCIUM MODULATING AGENT PHARMACIA CORPORATION (US) 2004-11-04 WO claimed
WO-2004087687-A1 CHROMENE DERIVATIVES AS ANTI-INFLAMMATORY AGENTS PHARMACIA CORPORATION (US) 2004-10-14 WO claimed
CN-1520324-A Antiangiogenic combination thereapy for treatment of cancer 2004-08-11 CN claimed
WO-2004056349-A2 METHODS AND COMPOSITIONS FOR THE TREATMENT OF HERPES VIRUS INFECTIONS USING CYCLOOXYGENASE-2 SELECTIVE INHIBITORS OR CYCLOOXYGENASE-2 INHIBITORS IN COMBINATION WITH ANTIVIRAL AGENTS PHARMACIA CORPORATION (US) 2004-07-08 WO claimed
WO-2004004833-A1 USE OF CYCLOOXYGENASE-2 SELECTIVE INHIBITORS AND THROMBOLYTIC AGENTS FOR THE TREATMENT OR PREVENTION OF A VASO-OCCLUSIVE EVENT PHARMACIA CORPORATION (US) 2004-01-15 WO claimed
EP-0977748-B1 SUBSTITUTED BENZOPYRAN DERIVATIVES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2003-03-26 EP claimed
EP-0977748-A1 SUBSTITUTED BENZOPYRAN DERIVATIVES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 2000-02-09 EP claimed
WO-1998047890-A1 SUBSTITUTED BENZOPYRAN DERIVATIVES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1998-10-29 WO claimed